Comparison of in vitro activities of voriconazole and five established antifungal agents against different species of dermatophytes using a broth macrodilution method

Journal of Clinical Microbiology

Volumn 39, Issue 1, 2001, Pages 385-388

  Perea, S ^a   Fothergill, A W ^a   Sutton, D A ^a   Rinaldi, M G ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; GRISEOFULVIN; ITRACONAZOLE; TERBINAFINE; VORICONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; DERMATOMYCOSIS; DILUTION; EPIDERMOPHYTON; IN VITRO STUDY; MICROSPORUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; TRICHOPHYTON;

ANTIFUNGAL AGENTS; ARTHRODERMATACEAE; DERMATOMYCOSES; HUMANS; MICROBIAL SENSITIVITY TESTS; PYRIMIDINES; TRIAZOLES;

ARTHRODERMATACEAE; EPIDERMOPHYTON; MICROSPORUM; TRICHOPHYTON;

EID: 0035162303     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.39.1.385-388.2001     Document Type: Article

References (18)

1. The triazole antifungal agents: A review of itraconazole and fluconazole
2. In vitro studies of two triazole antifungal agents (voriconazole UK-109,496 and fluconazole) against Candida species
3. In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens
4. Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi
5. Comparison of in vitro antifungal susceptibilities of conidia and hyphae of filamentous fungi
6. An overview of topical antifungal therapy in dermatomycoses. A North American perspective
7. Culture and identification of dermatophytes
8. Comparative study of susceptibilities of germinated and ungerminated conidia of Aspergillus fumigatus to various antifungal agents
9. In vitro evaluation of voriconazole against some clinically important fungi
10. Effects of incubation temperature, inoculum size, and time of reading of broth microdilution susceptibility test results for amphotericin B against Fusarium
11. Comparison study of broth macrodilution and microdilution antifungal susceptibility tests for the filamentous fungi
12. In vitro studies of activity of voriconazole (UK-109,496), a new triazole antifungal agent, against emerging and less-common mold pathogen
13. Oral terbinafine (Lamisil) in the treatment of fungal infections of the skin and nails
14. Itraconazole in the treatment of superficial mycoses: An open trial of 40 cases
15. The dermatophytes
16. In vitro evaluation of voriconazole against clinical isolates of yeasts, moulds and dermatophytes in comparison with itraconazole, ketoconazole, amphotericin B and griseofulvin